According to the findings of Makishima et al., type-1 mutations (FLT3, PTPN11, NRAS NPM1, IDH1, IDH2, and WT1, gene mutations) were acquired during MDS transformation to AML [44]. This evidence concerns the gene IDH2 and myelodysplastic syndrome.